Page 1158 - Williams Hematology ( PDFDrive )

1132 Part VIII: Monocytes and Macrophages Chapter 72: Gaucher Disease and Related Lysosomal Storage Diseases 1133

158. De Maria R, Rippo MR, Schuchman EH, et al: Acidic sphingomyelinase (ASM) is nec- 170. Vanier MT. Prenatal diagnosis of Niemann-Pick diseases types A, B and C. Prenat
essary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lym- Diagn 22:630, 2002.
phoid cells. J Exp Med 187:897, 1998. 171. Mount Sinai International Center for Types A and B Niemann-Pick Disease: http://
159. Carstea ED, Morris JA, Coleman KG, et al: Niemann-Pick C1 disease gene: Homology www.mssm.edu/niemann-pick
to mediators of cholesterol homeostasis. Science 277:228, 1997. 172. Daloze P, Delvin EE, Glorieux FH, et al: Replacement therapy for inherited enzyme
160. Park WD, O’Brien JF, Lundquist PA, et al: Identification of 58 novel mutations in deficiency: Liver orthotopic transplantation in Niemann-Pick disease type A. Am J Med
Niemann-Pick disease type C: Correlation with biochemical phenotype and impor- Genet 1:229, 1977.
tance of PTC1-like domains in NPC1. Hum Mutat 22:313, 2003. 173. Victor S, Coulter JB, Besley GT, et al: Niemann-Pick disease: Sixteen-year follow-up of
161. Millat G, Chikh K, Naureckiene S, et al: Niemann-Pick disease type C: Spectrum of allogeneic bone marrow transplantation in a type B variant. J Inherit Metab Dis 26:775,
HE1 mutations and genotype/phenotype correlations in the NPC2 group. Am J Hum 2003.
Genet 69:1013, 2001. 174. Hsu YS, Hwu WL, Huang SF, et al: Niemann-Pick disease type C (a cellular cholesterol
162. Verot L, Chikh K, Freydière E, et al: Niemann-Pick C disease: Functional character- lipidosis) treated by bone marrow transplantation. Bone Marrow Transplant 24:103,
ization of three NPC2 mutations and clinical and molecular update on patients with 1999.
NPC2. Clin Genet 71:320, 2007. 175. Miranda SR, Erlich S, Friedrich VL Jr, et al: Hematopoietic stem cell gene therapy leads
163. Pacheco CD, Kunkel R, Lieberman AP: Autophagy in Niemann-Pick C disease is to marked visceral organ improvements and a delayed onset of neurological abnormal-
dependent upon Beclin-1 and responsive to lipid trafficking defects. Hum Mol Genet ities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease.
16:1495, 2007. Gene Ther 7:1768, 2000.
164. Loftus SK, Morris JA, Carstea ED, et al: Murine model of Niemann-Pick C disease: 176. Lachmann RH, te Vruchte D, Lloyd-Evans E, et al: Treatment with miglustat reverses
Mutation in a cholesterol homeostasis gene. Science 277:232, 1997. the lipid-trafficking defect in Niemann-Pick disease type C. Neurobiol Dis 16:654, 2004.
165. Golde DW, Schneider EL, Bainton EL, et al: Pathogenesis of one variant of sea-blue 177. Patterson MC, Vecchio D, Prady H, et al: Miglustat for treatment of Niemann-Pick C
histiocytosis. Lab Invest 33:371, 1975. disease: A randomised controlled study. Lancet Neurol 6:765, 2007.
166. Patterson MC: A riddle wrapped in a mystery: Understanding Niemann-Pick disease, 178. Wraith JE, Vecchio D, Jacklin E, et al: Miglustat in adult and juvenile patients with
type C. Neurologist 9:301, 2003. Niemann-Pick disease type C: Long-term data from a clinical trial. Mol Genet Metab
167. Lazarus SS, Vethamany VG, Schneck L, et al: Fine structure and histochemistry of 99:351, 2010.
peripheral blood cells in Niemann-Pick disease. Lab Invest 17:155, 1967. 179. Patterson MC, Vecchio D, Jacklin E, et al: Long-term miglustat therapy in children with
168. Brady RO: Sphingomyelin lipidoses: Niemann-Pick disease, in The Metabolic Basis of Niemann-Pick disease type C. J Child Neurol 25:300, 2010.
Inherited Disease, edited by JB Stanbury, JB Wyngaarden, DS Fredrickson, JL Goldstein, 180. Jiang X, Sidhu R, Porter FD, et al: A sensitive and specific LC-MS/MS method for rapid
MS Brown, p 831. McGraw-Hill, New York, 1983. diagnosis of Niemann-Pick C1 disease from human plasma. J Lipid Res 52:1435, 2011.
169. Gal AE, Brady RO, Hibberg SR, et al: A practical chromogenic procedure for the detec- 181. Ohgane K, Karaki F, Dodo K, Hashimoto Y: Discovery of oxysterol-derived pharma-
tion of homozygotes and heterozygous carriers of Niemann-Pick disease. N Engl J Med cological chaperones for NPC1: Implication for the existence of second sterol-binding
293:632, 1975. site. Chem Biol 20:391, 2013.

Kaushansky_chapter 72_p1121-1134.indd 1133 9/17/15 3:53 PM